Alvotech (ALVO) Acquisitions (2022 - 2023)

Alvotech (ALVO) posted Acquisitions of $11.2 million for Q4 2023, down 83.2% on a QoQ basis from $66.4 million in Q4 2022, and down 83.2% year-over-year from $66.4 million in Q4 2022.

Alvotech (ALVO) Acquisitions (2022 - 2023) Analysis & Trends

Alvotech's Acquisitions history runs 2 years deep, the most recent figure standing at $11.2 million for Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Alvotech 935.87 Mn 935.87 Mn 5.09 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 11.16 Mn
Dec 31, 2022 66.43 Mn